Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Ryerson University

$25,000.00

Mass Transfer Coefficient Measurement in Single-use Bioreactor - Application of the Endoscopy Technique

FY 2018-19

Summary
There is an enormous demand to provide vaccines at higher scales and lower costs. Currently the economically*optimized solution seems to employ larger size single-use bioprocessing systems. This results in lowering*existing vaccines production cost and ultimately facilitating the development of new vaccines.*Sanofi Pasteur has the broadest available range of vaccines, protecting population against 20 out of 26*infectious diseases. The vaccines division of Sanofi, one of Canada's largest vaccine producing company is*interested in utilizing a single-use aerated stirred bioreactor for the production of vaccines at an industrial scale.*Despite the common use of the aerated stirred bioreactors, knowledge about the influence of various process*variables on performance of the single-use bioprocessing system is still limited. The performance of the aerated*stirred bioreactors utilized in numerous industries is highly dependent on the ability to transfer oxygen from the*gas phase to the liquid phase inside the reactors. A key part of understanding the mass transfer of oxygen is*related to being able to determine the size of the gas bubbles in the bioreactors. Therefore the goals in the*proposed research project are to investigate the hydrodynamics of gas/liquid interaction in the bioreactors as a*function of the design parameters and operating conditions and to develop an optimal design in obtaining an*efficient oxygen mass transfer rate, explicitly the volumetric mass-transfer coefficient, required for the vaccine*production inside of the aerated stirred bioreactor. To achieve these objectives, extensive experimentations*including advanced visualization and image analysis technique such as endoscopy (EnviroCam), and optical*dissolved oxygen meter (DO) are employed.*Results from the proposed project will enable the Canadian bioprocessing companies and vaccine*manufacturers to apply the single-use bioreactors in their production systems. This will lead to an enhanced*product quality, efficient use of power, increased production capacity, and capital/operational cost savings.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
528359-2018
Name nom
Lohi, Ali
Department département
Chemical Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1206
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Engineering
Area of application fr
Génie
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
1
Nb partie
1
Application title
Mass Transfer Coefficient Measurement in Single-use Bioreactor - Application of the Endoscopy Technique
Keyword
NSERC
Application summary
There is an enormous demand to provide vaccines at higher scales and lower costs. Currently the economically*optimized solution seems to employ larger size single-use bioprocessing systems. This results in lowering*existing vaccines production cost and ultimately facilitating the development of new vaccines.*Sanofi Pasteur has the broadest available range of vaccines, protecting population against 20 out of 26*infectious diseases. The vaccines division of Sanofi, one of Canada's largest vaccine producing company is*interested in utilizing a single-use aerated stirred bioreactor for the production of vaccines at an industrial scale.*Despite the common use of the aerated stirred bioreactors, knowledge about the influence of various process*variables on performance of the single-use bioprocessing system is still limited. The performance of the aerated*stirred bioreactors utilized in numerous industries is highly dependent on the ability to transfer oxygen from the*gas phase to the liquid phase inside the reactors. A key part of understanding the mass transfer of oxygen is*related to being able to determine the size of the gas bubbles in the bioreactors. Therefore the goals in the*proposed research project are to investigate the hydrodynamics of gas/liquid interaction in the bioreactors as a*function of the design parameters and operating conditions and to develop an optimal design in obtaining an*efficient oxygen mass transfer rate, explicitly the volumetric mass-transfer coefficient, required for the vaccine*production inside of the aerated stirred bioreactor. To achieve these objectives, extensive experimentations*including advanced visualization and image analysis technique such as endoscopy (EnviroCam), and optical*dissolved oxygen meter (DO) are employed.*Results from the proposed project will enable the Canadian bioprocessing companies and vaccine*manufacturers to apply the single-use bioreactors in their production systems. This will lead to an enhanced*product quality, efficient use of power, increased production capacity, and capital/operational cost savings.